Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 987

Results For "IT"

10131 News Found

Scientists from BRICS work on genomic sequencing of Covid-19
Drug Approval | August 06, 2021

Scientists from BRICS work on genomic sequencing of Covid-19

Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread


NPPA issues notice to manufacturers and importers of knee implants
Policy | August 05, 2021

NPPA issues notice to manufacturers and importers of knee implants

The data should be submitted by August 12th 2021


Biotech-PRIDE guidelines released
Biotech | August 05, 2021

Biotech-PRIDE guidelines released

Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.


Alembic gets USFDA nod for Clomipramine Hydrochloride
News | August 05, 2021

Alembic gets USFDA nod for Clomipramine Hydrochloride

It had an estimated market size of US $ 32 million as of June 2021


Clarivate  acquires Bioinfogate
Digitisation | August 05, 2021

Clarivate acquires Bioinfogate

Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences


Lyka Labs reports improved set of numbers in Q1FY22
News | August 05, 2021

Lyka Labs reports improved set of numbers in Q1FY22

The company has been consistently reducing debt


Covaxin receives approval from Hungary
Biotech | August 05, 2021

Covaxin receives approval from Hungary

More countries recognise Covaxin


ACG Films & Foils partners Danapak Flexibles A/S for the Indian market
Packaging | August 05, 2021

ACG Films & Foils partners Danapak Flexibles A/S for the Indian market

Innovative solutions and a deep understanding of the market makes this a unique combination


IPCA Labs  reports Q1FY22 net at Rs 306.66 Cr
News | August 05, 2021

IPCA Labs reports Q1FY22 net at Rs 306.66 Cr

Total income grew in the quarter


Caplin Point Laboratories posts consolidated PAT in Q1FY22 at Rs 70.85 Cr
News | August 05, 2021

Caplin Point Laboratories posts consolidated PAT in Q1FY22 at Rs 70.85 Cr

EPS climbs to Rs 9.25 for the quarter